Shopping Cart
Remove All
Your shopping cart is currently empty
TGF-β2-IN-1 is a selective inhibitor of TGF-β2. It exhibits potent antiproliferative effects on HCT-116, Caco-2, and HT-29 cells, with IC50 values of 6.84, 10.21, and 9.47 μM, respectively. TGF-β2-IN-1 inhibits TGF-β2 signaling in a dose-dependent manner by suppressing receptor and cytokine expression. This compound is useful for colorectal cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | TGF-β2-IN-1 is a selective inhibitor of TGF-β2. It exhibits potent antiproliferative effects on HCT-116, Caco-2, and HT-29 cells, with IC50 values of 6.84, 10.21, and 9.47 μM, respectively. TGF-β2-IN-1 inhibits TGF-β2 signaling in a dose-dependent manner by suppressing receptor and cytokine expression. This compound is useful for colorectal cancer research. |
| In vitro | TGF-β2-IN-1 (Compound 10k) exhibits potent antiproliferative effects on HCT-116 (IC50 = 6.84 μM), Caco-2 (IC50 = 10.21 μM), and HT-29 (IC50 = 9.47 μM) at concentrations of 1.562-100 μM over 48 hours. It progressively reduces TGF-β2 receptor and cytokine levels in HCT-116 cells within the same concentration and time frame. At 50-100 μM for 48 hours, it does not significantly induce apoptosis or necrosis in HCT-116 cells. The compound demonstrates strong binding affinity to the TGF-β receptor II with an IFD XP Glide score of 11.28 kcal/mol. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.